Holland Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Holland Capital Management's GILD Position: Q2 2017 in Review
Holland Capital Management reduced its Gilead Sciences (GILD) stake by 4.3% in Q2 2017, selling an estimated $1.17M and leaving 386,511 shares worth $27.4M. The position accounts for 1.2% of the portfolio, ranked #36.
Holland Capital Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $167M in Q3 2014. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.
- Holland Capital Management held 386,511 shares of Gilead Sciences worth $27.4M as of Q2 2017.
- Holland Capital Management sold 17,552 Gilead Sciences shares in Q2 2017, an estimated $1.17M.
- Gilead Sciences made up 1.2% of Holland Capital Management's portfolio in Q2 2017, its #36 holding.
- Holland Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
- Holland Capital Management's Gilead Sciences position peaked at $167M in Q3 2014.
- 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.
Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.